The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer.

[1]  Jonathan L Rees,et al.  Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial]. , 2015, Health technology assessment.

[2]  A. Napoli,et al.  Systematic review of high‐intensity focused ultrasound ablation in the treatment of breast cancer , 2015, The British journal of surgery.

[3]  C. Robertson,et al.  Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. , 2015, Health technology assessment.

[4]  M. Menon,et al.  Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer. , 2015, European urology.

[5]  Joo Ha Hwang,et al.  Emerging HIFU applications in cancer therapy , 2015, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[6]  You-Ping Li,et al.  High‐intensity focused ultrasound for treatment of pancreatic cancer: a systematic review , 2014, Journal of evidence-based medicine.

[7]  R. DiPaola,et al.  Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. , 2014, JAMA internal medicine.

[8]  N. Keating,et al.  Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  David C. Miller,et al.  Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology , 2014 .

[10]  Hans Garmo,et al.  Radical prostatectomy or watchful waiting in early prostate cancer. , 2014, The New England journal of medicine.

[11]  E. Bastiaannet,et al.  Breast-Conserving Surgery With or Without Radiotherapy in Older Breast Patients With Early Stage Breast Cancer: A Systematic Review and Meta-analysis , 2014, Annals of Surgical Oncology.

[12]  P. Wiklund,et al.  Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes , 2014, BMJ : British Medical Journal.

[13]  J. Galvin,et al.  Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. , 2013, International journal of radiation oncology, biology, physics.

[14]  C. Parker,et al.  SABRE 1 (Surgery Against Brachytherapy – a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low–intermediate risk clinically localised prostate cancer , 2013, BJU international.

[15]  J. Stanford,et al.  Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. , 2013, Journal of the National Cancer Institute.

[16]  Steven E Schild,et al.  Re: Proton vs intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. , 2013, Journal of the National Cancer Institute.

[17]  J. L. Bermejo,et al.  Long‐term oncological outcomes after laparoscopic radical prostatectomy , 2013, BJU international.

[18]  M. Zelefsky,et al.  Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. , 2012, International journal of radiation oncology, biology, physics.

[19]  Timothy J Wilt,et al.  Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.

[20]  Ronald C. Chen,et al.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. , 2012, JAMA.

[21]  B. Guillonneau,et al.  A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. , 2012, European urology.

[22]  J. Epstein,et al.  Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center. , 2012, Human pathology.

[23]  P. Corso,et al.  NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer. , 2011, NIH consensus and state-of-the-science statements.

[24]  P. Ghadjar,et al.  Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. , 2011, Cancer.

[25]  Rosalia Viterbo,et al.  Long‐term survival after radical prostatectomy versus external‐beam radiotherapy for patients with high‐risk prostate cancer , 2011, Cancer.

[26]  C. Simone.  Re: Firas Abdollah, Maxine Sun, Rodolphe Thuret, et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. Eur Urol 2011;59:88-95. , 2011, European urology.

[27]  M. Menon,et al.  Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up. , 2010, European urology.

[28]  F. Hamdy,et al.  Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. , 2010, European journal of cancer.

[29]  P. Scardino,et al.  Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A. Weizer,et al.  Margin control in robotic and laparoscopic prostatectomy: what are the REAL outcomes? , 2010, Urologic oncology.

[31]  B. Donnelly,et al.  A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer , 2010, Cancer.

[32]  B. Donnelly,et al.  A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer , 2009, Cancer.

[33]  C. Giberti,et al.  Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study , 2009, World Journal of Urology.

[34]  B. Guillonneau,et al.  Platinum Priority – Prostate Cancer , 2009 .

[35]  J. Chapelon,et al.  Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. , 2009, European urology.

[36]  Bernhard Walter,et al.  First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. , 2008, European urology.

[37]  Xianglin L. Du,et al.  Long‐term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer , 2008, Journal of surgical oncology.

[38]  Dirk F Moore,et al.  Survival following primary androgen deprivation therapy among men with localized prostate cancer. , 2008, JAMA.

[39]  C. Lallas,et al.  The addition of robotic surgery to an established laparoscopic radical prostatectomy program: effect on positive surgical margins. , 2008, The Canadian journal of urology.

[40]  Oliver Sartor,et al.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. , 2007, The Journal of urology.

[41]  S. Herrell,et al.  A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. , 2007, The Journal of urology.

[42]  L. Wilson,et al.  Surgery Versus Implant for Early Prostate Cancer: Results From a Single Institution, 1992–2005 , 2007, Cancer journal.

[43]  A. D'Amico,et al.  Guideline for the management of clinically localized prostate cancer: 2007 update. , 2007, The Journal of urology.

[44]  Dirk De Ruysscher,et al.  Proton therapy in clinical practice: current clinical evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  Laura Curiel,et al.  Control of prostate cancer by transrectal HIFU in 227 patients. , 2007, European urology.

[46]  O. Ogawa,et al.  A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. , 2006, Japanese journal of clinical oncology.

[47]  J. Crook,et al.  Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  Paul Schellhammer,et al.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.

[49]  P. Johnstone,et al.  Radical prostatectomy for clinical T4 prostate cancer , 2006, Cancer.

[50]  Toyoaki Uchida,et al.  Five years experience of transrectal high‐intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer , 2006, International journal of urology : official journal of the Japanese Urological Association.

[51]  Patrick A Kupelian,et al.  Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. , 2005, International journal of radiation oncology, biology, physics.

[52]  K. Nihei,et al.  Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan. , 2005, Japanese journal of clinical oncology.

[53]  A. Gelet,et al.  Technology Insight: high-intensity focused ultrasound for urologic cancers , 2005, Nature Clinical Practice Urology.

[54]  M. Eble,et al.  Permanent 125I‐seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results , 2004, BJU international.

[55]  William Preston,et al.  Proton therapy for prostate cancer: the initial Loma Linda University experience. , 2004, International journal of radiation oncology, biology, physics.

[56]  L. Curiel,et al.  Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. , 2004, Urology.

[57]  Bernhard Walter,et al.  High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. , 2004, Urology.

[58]  Victor Reuter,et al.  Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. , 2003, The Journal of urology.

[59]  Amnon Zisman,et al.  Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. , 2003, The Journal of urology.

[60]  P. Walsh.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2003, The Journal of urology.

[61]  L. Potters,et al.  Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[62]  C. Reddy,et al.  Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  Anil Kumar,et al.  Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. , 2002, Urology.

[64]  Patrick A Kupelian,et al.  Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[65]  S. Stokes,et al.  Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. , 2000, International journal of radiation oncology, biology, physics.

[66]  J M Slater,et al.  Conformal proton therapy for early-stage prostate cancer. , 1999, Urology.

[67]  S B Malkowicz,et al.  Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .

[68]  L. Verhey,et al.  Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. , 1995, International journal of radiation oncology, biology, physics.

[69]  J. Chapelon,et al.  Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. , 1993, Journal of endourology.

[70]  R. Écochard,et al.  In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. , 1992, Cancer research.

[71]  W Hinshaw,et al.  Radical surgery versus radiotherapy for adenocarcinoma of the prostate. , 1982, The Journal of urology.

[72]  A. D'Amico,et al.  Prostate cancer, version 2.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[73]  Cary P Gross,et al.  Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. , 2013, Journal of the National Cancer Institute.

[74]  A. Mottrie,et al.  Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years. , 2012, Urology.

[75]  F. Montorsi,et al.  A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. , 2011, European urology.

[76]  Daniel W. Miller,et al.  Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study. , 1997, International journal of radiation oncology, biology, physics.